Nanologica operates in the field of nanotechnology. Currently the main business focus is on the sectors Drug Delivery and Chromatography, which includes the development of pharmaceutical administration and technology used for the separation and purification of products. The research is carried out in collaboration with Stockholm University and the Ångström Laboratory at Uppsala University. The company was founded in 2004 and is based in Södertälje.

Quotes for Nanologica AB

Right Now

+/-
-0.65
%
-5,28%
Latest
11.65
High
12.5
Low
11.5
Volume
50 907
Turnover (SEK)
600 936
Value (MSEK)
322,7

Board

CEO

  • Andreas Bhagwani

Chairman Of The Board

  • Gisela Sitbon

Board

  • Anders Rabbe
  • Eva Byröd
  • Lena Torlegård
  • Mattias Bengtsson
  • Tomas Kramar

Videos

Largest Owners

Name Capital % Votes % Date
Thomas Eldered 32,43 32,43 2020-06-30
Swedbank Robur Fonder 9,03 9,03 2020-10-31
Andreas Bhagwani 5,95 5,95 2020-09-30
Avanza Pension 3,83 3,83 2020-09-30
Kungliga Konstakademien 2,89 2,89 2020-09-30
Mikael Lönn 2,02 2,02 2020-09-30
CJ Invest 1,99 1,99 2020-09-30
Alfonso Garcia-Bennett 1,98 1,98 2020-09-30
Niklas Sjöblom 1,59 1,59 2020-09-30
Wilhelm Risberg 1,35 1,35 2020-09-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream